Increased expression of squamous cell carcinoma antigen 1 and 2 in mycosis fungoides and Sézary syndrome

被引：0
|
作者：
Kenta Oka
Takuya Miyagawa
Hiraku Suga
Tomomitsu Miyagaki
Yuka Mizuno
Hiroaki Kamijo
Teruyoshi Hisamoto
Issei Omori
Hikari Boki
Tomonori Oka
Naomi Takahashi-Shishido
Makoto Sugaya
Shinichi Sato
机构：
[1] University of Tokyo Graduate School of Medicine,Department of Dermatology
[2] St. Marianna University School of Medicine,Department of Dermatology
[3] International University of Health and Welfare,Department of Dermatology
来源：
European Journal of Dermatology | 2022年 / 32卷
关键词：
atopic dermatitis; cutaneous T-cell lymphoma; mycosis fungoides; Sézary syndrome; squamous cell carcinoma antigen;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：464 / 470
页数：6
相关论文
共 50 条
  • [1] Increased Expression of Squamous Cell Carcinoma Antigen 1 and 2 in Mycosis Fungoides and Se′zary Syndrome
    Oka, K.
    Miyagawa, T.
    Suga, H.
    Miyagaki, T.
    Mizuno, Y.
    Hisamoto, T.
    Omori, I.
    Boki, H.
    Takahashi-Shishido, N.
    Sato, S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (12) : S262 - S262
  • [2] Increased expression of squamous cell carcinoma antigen 1 and 2 in mycosis fungoides and Sezary syndrome
    Oka, Kenta
    Miyagawa, Takuya
    Suga, Hiraku
    Miyagaki, Tomomitsu
    Mizuno, Yuka
    Kamijo, Hiroaki
    Hisamoto, Teruyoshi
    Omori, Issei
    Boki, Hikari
    Oka, Tomonori
    Takahashi-Shishido, Naomi
    Sugaya, Makoto
    Sato, Shinichi
    EUROPEAN JOURNAL OF DERMATOLOGY, 2022, 32 (04) : 464 - 470
  • [3] Multidisciplinary Management of Mycosis Fungoides/Sézary Syndrome
    Sara Berg
    Jennifer Villasenor-Park
    Paul Haun
    Ellen J. Kim
    Current Hematologic Malignancy Reports, 2017, 12 : 234 - 243
  • [4] Abnormal expression of interleukin-23 in mycosis fungoides/Sézary syndrome lesions
    Sean D. Doherty
    Xiao Ni
    Christy B. Doherty
    Dan Jones
    Xing Zhao
    Laurie B. Owen
    Madeleine Duvic
    Archives of Dermatological Research, 2007, 298 : 353 - 356
  • [5] Therapeutic reduction of cell-mediated immunosuppression in mycosis fungoides and Sézary syndrome
    Larisa J. Geskin
    Oleg E. Akilov
    Soonyou Kwon
    Michael Schowalter
    Simon Watkins
    Theresa L. Whiteside
    Lisa H. Butterfield
    Louis D. Falo
    Cancer Immunology, Immunotherapy, 2018, 67 : 423 - 434
  • [6] Lebensqualität von Patienten mit Mycosis fungoides und Sézary-SyndromQuality of Life of Patients With Mycosis Fungoides and Sézary Syndrome
    Manuel Jäger
    Deniz Özistanbullu
    Claus-Detlev Klemke
    Sabine Tratzmiller
    hautnah, 2023, 22 (3) : 156 - 160
  • [7] Mycosis Fungoides and Sézary Syndrome: Updates and Review of Current Therapy
    Hiroaki Kamijo
    Tomomitsu Miyagaki
    Current Treatment Options in Oncology, 2021, 22
  • [8] Systemic treatments with monoclonal antibodies in mycosis fungoides and Sézary syndrome
    Ibatici, Adalberto
    Angelucci, Emanuele
    Massone, Cesare
    DERMATOLOGY REPORTS, 2024, 16
  • [9] Management of Mycosis Fungoides and Sézary Syndrome With Oral Systemic Therapies
    Greenzaid, Jonathan D.
    Thakker, Sach
    Ruley, Ainsley J.
    Eichinger, Justin M.
    Strowd, Lindsay C.
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2025,
  • [10] Regulatory T cells and immunodeficiency in mycosis fungoides and Sézary syndrome
    T Krejsgaard
    N Odum
    C Geisler
    M A Wasik
    A Woetmann
    Leukemia, 2012, 26 : 424 - 432
12345